PIWORLD Investor Podcasts

This video can be seen at: https://www.piworld.co.uk/2020/05/12/open-orphan-orph-sharesoc-presentation-11th-may-2020/
 
Open Orphan Executive Chairman Cathal Friel presents an update at the ShareSoc Growth Company webinar 11th May 2020.
Introduction from Mike Dennis, ShareSoc – 00:23
Cathal Friel, Executive Chairman, Open Orphan.Introduction – 00:55About Open Orphan – 01:33Management team – 08:39Complementary Services Business – 10:26World’s first Coronavirus challenge model – 11:28About hVIVO – 14:19Vaccine and Pharmaceutical product portfolio – 15:39Genomic data capturing – 17:06Contracts – 17:53Open Orphan strategy – 18:07hVIVO strategy – 18:17Combined pipeline – 18:20Revenue synergies – 19:42Revenue growth and profitability – 21:30Q&A – 23:25
Open Orphan PLC is a European-focussed, rare and orphan drug consulting services platform. The company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups. The company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.Venn Life Sciences Holdings PLC is engaged into a Clinical Research Organisation (CRO) providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

Show Notes

This video can be seen at: https://www.piworld.co.uk/2020/05/12/open-orphan-orph-sharesoc-presentation-11th-may-2020/

 

Open Orphan Executive Chairman Cathal Friel presents an update at the ShareSoc Growth Company webinar 11th May 2020.

Introduction from Mike Dennis, ShareSoc – 00:23

Cathal Friel, Executive Chairman, Open Orphan.
Introduction – 00:55
About Open Orphan – 01:33
Management team – 08:39
Complementary Services Business – 10:26
World’s first Coronavirus challenge model – 11:28
About hVIVO – 14:19
Vaccine and Pharmaceutical product portfolio – 15:39
Genomic data capturing – 17:06
Contracts – 17:53
Open Orphan strategy – 18:07
hVIVO strategy – 18:17
Combined pipeline – 18:20
Revenue synergies – 19:42
Revenue growth and profitability – 21:30
Q&A – 23:25

Open Orphan PLC is a European-focussed, rare and orphan drug consulting services platform. The company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups. The company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.Venn Life Sciences Holdings PLC is engaged into a Clinical Research Organisation (CRO) providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

Creators and Guests

P
Producer
PIWORLD

What is PIWORLD Investor Podcasts?

Content for investors by investors . These are audio podcast versions of our videos. Sometimes slides are referred to, to view as videos go to www.piworld.co.uk